XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.330
-0.030 (-1.27%)
At close: Feb 26, 2026, 4:00 PM EST
2.350
+0.020 (0.86%)
After-hours: Feb 26, 2026, 4:00 PM EST
XBiotech Market Cap
XBiotech has a market cap or net worth of $71.04 million as of February 26, 2026. Its market cap has decreased by -29.81% in one year.
Market Cap
71.04M
Enterprise Value
-75.42M
1-Year Change
-29.81%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $71.04M, a decrease of -90.37%. That is a compound annual growth rate of -19.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 72.00M | -1.23% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 77.73M |
| Seres Therapeutics | 76.80M |
| PolyPid | 76.46M |
| Pelthos Therapeutics | 76.16M |
| Adicet Bio | 73.98M |
| eXoZymes | 73.80M |
| Entera Bio | 72.00M |
| Kazia Therapeutics | 71.26M |